Cohort Study of the Clinical Course of Macular Diseases in Kagawa (Kagawa Macula Cohort Study)

Trial Profile

Cohort Study of the Clinical Course of Macular Diseases in Kagawa (Kagawa Macula Cohort Study)

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 29 Dec 2014

At a glance

  • Drugs Aflibercept (Primary) ; Pegaptanib (Primary) ; Ranibizumab (Primary) ; Verteporfin (Primary)
  • Indications Age-related macular degeneration; Central serous chorioretinopathy; Choroidal neovascularisation; Diabetic macular oedema; Retinal perforations; Retinal vein occlusion
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Dec 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top